Common use of Generic Drugs Clause in Contracts

Generic Drugs. Drugs that (1) are approved by the Food and Drug Administration (FDA) as a therapeutic equivalent to the Brand Name Drug, (2) contain the same active ingredient as the Brand Name Drug, and (3) cost less than the Formulary Brand Name Drug equivalent. Home Self-Administered Injectables - Home Self- Administered Injectable medications are defined as those Drugs that are Medically Necessary; administered more often than once a month by the patient or family mem- ber; administered subcutaneously or intramuscularly; deemed safe for self-administration as determined by Blue Shield of California’s Pharmacy and Therapeutics Committee; prior authorized by Blue Shield of Califor- nia; and obtained from a Blue Shield of California Spe- cialty Pharmacy. Intravenous (IV) medications (i.e. those medications administered directly into a vein) are not considered Home Self-Administered Injectable Non-Formulary Drugs — Drugs determined by the Blue Shield Pharmacy and Therapeutics Committee as being duplicative or as having preferred Formulary Drugs alternatives available. Benefits are provided for Non-Formulary Drugs and are always subject to the Non-Formulary Copayment. Non-Participating Pharmacy — a pharmacy which does not participate in the Blue Shield of California Pharmacy Network. Participating Pharmacy — a pharmacy that participates in the Blue Shield Pharmacy Network. These Participat- ing Pharmacies have agreed to a contracted rate for cov- ered prescriptions for Blue Shield Subscribers and De- pendents. Specialty Pharmacy Network – select Participating Pharmacies contracted by Blue Shield of California to provide covered Home Self-Administered Injectables. These pharmacies offer 24-hour clinical services and provide prompt home delivery of Home Self- Administered Injectables.

Generic Drugs. Drugs that (1) are approved by the Food and Drug Administration (FDA) as a therapeutic equivalent to the Brand Name Drug, (2) contain the same active ingredient as the Brand Name Drug, and (3) cost less than the Formulary Brand Name Drug equivalent. Home Self-Administered Injectables - – Home Self- Administered Injectable medications are defined as those Drugs that are Medically Necessary; administered more often than once a month by the patient or family mem- ber; administered subcutaneously or intramuscularly; deemed safe for self-administration as determined by Blue Shield of California’s Pharmacy and Therapeutics Committee; prior authorized by Blue Shield of Califor- nia; and obtained from a Blue Shield of California Spe- cialty Pharmacy. Intravenous (IV) medications (i.e. those medications administered directly into a vein) are not considered Home Self-Administered Injectable drugs. Home Self-Administered Injectables are listed in Blue Shield’s Drug Formulary. Non-Formulary Drugs — Drugs determined by the Blue Shield Pharmacy and Therapeutics Committee as being duplicative or as having preferred Formulary Drugs alternatives available. Benefits are provided for Non-Formulary Drugs and are always subject to the Non-Formulary Copayment. Non-Participating Pharmacy — a pharmacy which does not participate in the Blue Shield of California Pharmacy Network. Participating Pharmacy — a pharmacy that participates in the Blue Shield Pharmacy Network. These Participat- ing Pharmacies have agreed to a contracted rate for cov- ered prescriptions for Blue Shield Subscribers and De- pendents. Specialty Pharmacy Network – select Participating Pharmacies contracted by Blue Shield of California to provide covered Home Self-Administered Injectables. These pharmacies offer 24-hour clinical services and provide prompt home delivery of Home Self- Administered Injectables.

Generic Drugs. Drugs that (1) are approved by the Food and Drug Administration (FDA) as a therapeutic and equivalent to the Brand Name Drug, (2) contain the same active ingredient as the Brand Name Drug, and (3) cost less than the Formulary Brand Name Drug equivalentequiva- lent. Home Self-Administered Injectables - – Home Self- Administered Injectable medications are defined as those Drugs that are Medically Necessary; administered more often than once a month by the patient or family mem- ber; administered subcutaneously or intramuscularly; deemed safe for self-administration as determined by Blue Shield of California’s Pharmacy and Therapeutics Committee; prior authorized by Blue Shield of Califor- nia; and obtained from a Blue Shield of California Spe- cialty Pharmacy. Intravenous (IV) medications (i.e. those medications administered directly into a vein) are not considered Home Self-Administered Injectable drugs. Home Self-Administered Injectables are listed in Blue Shield Drug Formulary. Non-Formulary Drugs — Drugs determined by the Blue Shield Shield’s Pharmacy and Therapeutics Committee as being duplicative or as having preferred Formulary Drugs alternatives available. Benefits are provided for Non-Formulary Drugs and are always subject to the Non-Formulary Copayment. Non-Participating Pharmacy — a pharmacy which does not participate in the Blue Shield of California Pharmacy Network. Participating Pharmacy — a pharmacy that participates in the Blue Shield of California Pharmacy Network. These Participat- ing Participating Pharmacies have agreed to a contracted con- tracted rate for cov- ered covered prescriptions for Blue Shield Subscribers and De- pendentsDependents. Specialty Pharmacy Network – select Participating Pharmacies contracted by Blue Shield of California to provide covered Home Self-Administered Injectables. These pharmacies offer 24-hour clinical services and provide prompt home delivery of Home Self- Administered Injectables.

Generic Drugs. Drugs that (1) are approved by the Food and Drug Administration (FDA) as a therapeutic equivalent to the Brand Name Drug, (2) contain the same active ingredient as the Brand Name Drug, and (3) cost less than the Formulary Brand Name Drug equivalent. Home Self-Administered Injectables - Home Self- Administered Injectable medications are defined as those Drugs that are Medically Necessary; administered more often than once a month by the patient or family mem- ber; administered subcutaneously or intramuscularly; deemed safe for self-administration as determined by Blue Shield of California’s Pharmacy and Therapeutics Committee; prior authorized by Blue Shield of Califor- nia; and obtained from a Blue Shield of California Spe- cialty Pharmacy. Intravenous (IV) medications (i.e. those medications administered directly into a vein) are not considered Home Self-Administered Injectable drugs. Home Self-Administered Injectables are listed in Blue Shield’s Drug Formulary. Non-Formulary Drugs — Drugs determined by the Blue Shield Pharmacy and Therapeutics Committee as being duplicative or as having preferred Formulary Drugs alternatives available. Benefits are provided for Non-Formulary Drugs and are always subject to the Non-Formulary Copayment. Non-Participating Pharmacy — a pharmacy which does not participate in the Blue Shield of California Pharmacy Network. Participating Pharmacy — a pharmacy that participates in the Blue Shield Pharmacy Network. These Participat- ing Pharmacies have agreed to a contracted rate for cov- ered prescriptions for Blue Shield Subscribers and De- pendents. Specialty Pharmacy Network – select Participating Pharmacies contracted by Blue Shield of California to provide covered Home Self-Administered Injectables. These pharmacies offer 24-hour clinical services and provide prompt home delivery of Home Self- Administered Injectables.